ArticleJournal of robotic surgery2026
Robot-assisted pancreatic necrosectomy for infected pancreatic necrosis secondary to severe acute pancreatitis: a single-center retrospective cohort study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An exploratory bibliometric analysis of robot-assisted ligament repair and reconstruction surgery worldwide.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Infected pancreatic necrosis (IPN) is a severe late complication of severe acute pancreatitis (SAP). Although step-up treatment has reduced the need for open pancreatic necrosectomy (OPN), the role of robot-assisted pancreatic necrosectomy (RAPN) remains unclear. We retrospectively analyzed 107 patients with SAP-related IPN who underwent surgery after failed conservative therapy and percutaneous catheter drainage from January 2020 to December 2025. Patients were grouped as RAPN (n = 26), conventional minimally invasive surgery (CMIS; n = 47), or OPN (n = 34). Outcomes and single-intervention success were compared, and logistic regression identified associated factors. Measured baseline characteristics did not differ significantly among groups. RAPN had longer operative time than CMIS and OPN, but less blood loss and fewer drainage tubes than OPN. No RAPN patient required postoperative intensive care. RAPN was associated with shorter urinary catheterization, less analgesic use, fewer severe treatment-related adverse events, and fewer overall complications than OPN, and with earlier ambulation and higher single-intervention success than CMIS. RAPN independently predicted single-intervention success (OR, 4.767; 95% CI, 1.280-17.754; p = 0.020), whereas higher modified CT severity index score reduced the odds of success (OR, 0.624; 95% CI, 0.438-0.890; p = 0.009). Total surgery-related hospitalization costs were similar. RAPN appears safe and feasible for selected SAP-related IPN patients within a step-up framework. Its favorable recovery and complication profile should be interpreted cautiously because of the retrospective design and possible selection bias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.